TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35156458

Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 42

Group type: COMPARATOR
Intervention: FS-LASIK
Number of subjects: 42
Study: 33092901

Group type: EXPERIMENTAL
Intervention: Intragastric botulinum toxin A
Number of subjects: 52

Group type: COMPARATOR
Intervention: Physiological saline solution
Number of subjects: 52
Study: 35805529

Group type: EXPERIMENTAL
Intervention: Physical activity program and high-protein supplementation (1.3 g/kg BW/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-protein supplementation (1.3 g/kg BW/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (daily routine)
Number of subjects: 60
Study: 33238991

Group type: EXPERIMENTAL
Intervention: eASCs (Cx611) administered intravenously at a dose of 160 million cells (2 million cells/mL, total volume 80 mL) on Day 1 and Day 3
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo (Ringer Lactate) administered intravenously at the same quantity (total volume of 80 mL) and schedule as the active treatment
Number of subjects: 180
Study: 35023356

Group type: EXPERIMENTAL
Intervention: Shared Decision-Making (SDM) tool (Anticoagulation Choice)
Number of subjects: 922

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 922
Study: 33539552

Group type: COMPARATOR
Intervention: Hand-washing promotion (education activities, sometimes with provision of soap) in child day-care centres or schools
Number of subjects: 84966

Group type: COMPARATOR
Intervention: Hand-washing promotion in LMICs
Number of subjects: 84966

Group type: COMPARATOR
Intervention: Hand-washing promotion among communities in LMICs
Number of subjects: 84966

Group type: COMPARATOR
Intervention: Hand-washing promotion with soap provided
Number of subjects: 84966

Group type: COMPARATOR
Intervention: Education only (no soap provided)
Number of subjects: 84966

Group type: COMPARATOR
Intervention: Hand-washing promotion in a hospital among a high-risk population
Number of subjects: 84966

Group type: COMPARATOR
Intervention: Hand-washing frequency in the hospital trial
Number of subjects: 84966
Study: 32189061

Group type: EXPERIMENTAL
Intervention: HOT (35 °C)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: TEMP (21 °C)
Number of subjects: 7
Study: 34433306

Group type: EXPERIMENTAL
Intervention: Cognitive assessment after randomization but before assigned treatment, using a cognitive battery developed in the REGARDS Study.
Number of subjects: 1000
Study: 35633025

Group type: EXPERIMENTAL
Intervention: Galcanezumab 300 mg subcutaneously once a month
Number of subjects: 164
Study: 34076688

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 35447353

Group type: EXPERIMENTAL
Intervention: Moderate intensity continuous training
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: High intensity interval training
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 105
Study: 34135038

Group type: EXPERIMENTAL
Intervention: 10-hour time-restricted eating (TRE)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard of care (Mediterranean diet nutritional counselling)
Number of subjects: 150
Study: 32664127

Group type: EXPERIMENTAL
Intervention: VieScope
Number of subjects: 55
Study: 35022943

Group type: EXPERIMENTAL
Intervention: Parent coaching (PC) intervention for 24 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Enhanced community treatment (ECT)
Number of subjects: 49
Study: 32303210

Group type: EXPERIMENTAL
Intervention: Oral nystatin (1 ml three times a day)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Sterile water (1 ml three times a day)
Number of subjects: 95
Study: 34636112

Group type: EXPERIMENTAL
Intervention: Eptacog beta (EB) at doses of 75 or 225 μg/kg for bleeding episodes and 75 μg/kg or 200 μg/kg for perioperative care.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Eptacog beta (EB) for perioperative care (75 μg/kg for minor procedures, 200 μg/kg for major surgeries).
Number of subjects: 60
Study: 32371513

Group type: EXPERIMENTAL
Intervention: Comprehensive health profiles including assessments of physical health, cognitive functioning, emotional state, social connectedness, quality of life, and more.
Number of subjects: 1000
Study: 33065651

Group type: EXPERIMENTAL
Intervention: Sentinel Node Biopsy (SNB) only
Number of subjects: 353

Group type: COMPARATOR
Intervention: Sentinel Node Biopsy + Axillary Dissection (SNB + AD)
Number of subjects: 353
Study: 34071782

Group type: EXPERIMENTAL
Intervention: Online health application supported by a mobile telephone or tablet (mHealth)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 240
Study: 2010124724

Group type: EXPERIMENTAL
Intervention: parecoxib-sodium 40 mg intravenously after operation
Number of subjects: 60
Study: 35500381

Group type: EXPERIMENTAL
Intervention: Fermented brown rice beverage (BA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fermented white rice beverage (WA)
Number of subjects: 40
Study: 32322017

Group type: EXPERIMENTAL
Intervention: Goldmann Applanation Tonometry (GAT) by ophthalmologists
Number of subjects: 116

Group type: COMPARATOR
Intervention: Goldmann Applanation Tonometry (GAT) by nurses
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Ocular Response Analyzer (ORA)
Number of subjects: 116
Study: 33454249

Group type: EXPERIMENTAL
Intervention: Coronary computed tomographic angiography (CCTA)
Number of subjects: 1728

Group type: EXPERIMENTAL
Intervention: CCTA with a threshold of ≥70% diameter stenosis (DS)
Number of subjects: 1728

Group type: EXPERIMENTAL
Intervention: CCTA of good-to-excellent quality
Number of subjects: 1728
Study: 32487982

Group type: EXPERIMENTAL
Intervention: Aerobic training (walking and/or running, 3 to 5 days/week)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Stretching (1 day/week)
Number of subjects: 75
Study: 35016998

Group type: EXPERIMENTAL
Intervention: Raspberry consumption (280 g/d for 8 weeks)
Number of subjects: 24
Study: 33932704

Group type: EXPERIMENTAL
Intervention: High intensity aerobic exercise (forced or voluntary modalities)
Number of subjects: 0
Study: 32272517

Group type: EXPERIMENTAL
Intervention: INhance Post‐Injection Serum with TriHex Technology®
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bland moisturizer
Number of subjects: 0
Study: 36468408

Group type: COMPARATOR
Intervention: Improved Alc‐IT (n=79)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Standard Alc‐IT (n=84)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control (unspecific inhibition training, n=79)
Number of subjects: 242
Study: 33546039

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medication treatment
Number of subjects: 0
Study: 32138961

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloons (DCB)
Number of subjects: 4590
Study: 34645402

Group type: EXPERIMENTAL
Intervention: Multicomponent school-based intervention (teacher training, education curriculum, environmental improvements)
Number of subjects: 921
Study: 35177255

Group type: EXPERIMENTAL
Intervention: OM85
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34196582

Group type: EXPERIMENTAL
Intervention: SBIRT implementation
Number of subjects: 20
Study: 35943946

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Training (ACT) program
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 143
Study: 34551918

Group type: EXPERIMENTAL
Intervention: Extended release metformin 3 g daily
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 35011603

Group type: EXPERIMENTAL
Intervention: 6-month lifestyle intervention
Number of subjects: 577

Group type: COMPARATOR
Intervention: Prompt infertility management (Control)
Number of subjects: 577
Study: 32602557

Group type: EXPERIMENTAL
Intervention: Physical therapy (group A)
Number of subjects: 62

Group type: COMPARATOR
Intervention: No physical therapy (group B)
Number of subjects: 62
Study: 34791943

Group type: EXPERIMENTAL
Intervention: FLAIR‐rSI (Fluid-attenuated inversion recovery relative signal intensity) quantified in stroke lesions
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Median times of last seen well
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Symptom recognition
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Estimated median stroke onset based on FLAIR‐rSI profiles
Number of subjects: 813
Study: 34169500

Group type: EXPERIMENTAL
Intervention: p-value threshold of 0.005
Number of subjects: 202

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 202
Study: 36181273

Group type: EXPERIMENTAL
Intervention: Suturing of sheath of peroneal tendons to the calcaneal plate using ethibond suture in a figure‐of‐8 shape.
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group of 12 surgically treated calcaneal fractures without PTI.
Number of subjects: 33
Study: 33653766

Group type: EXPERIMENTAL
Intervention: Nurse-led antimicrobial stewardship (AMS) programme
Number of subjects: 12
Study: 32883212

Group type: EXPERIMENTAL
Intervention: D-optimal blocking procedure for allocation to study arms
Number of subjects: 162

Group type: COMPARATOR
Intervention: Unstratified random allocation
Number of subjects: 162

Group type: COMPARATOR
Intervention: Stratified random allocation by first-visit group
Number of subjects: 162
Study: 35658604

Group type: EXPERIMENTAL
Intervention: Dabrafenib
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Dabrafenib + Trametinib
Number of subjects: 53
Study: 34211327

Group type: EXPERIMENTAL
Intervention: Dominant limb intervention (4-repetitions of 5-seconds knee extension maximal voluntary isometric contractions: MVIC)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Non-dominant limb intervention (4-repetitions of 5-seconds knee extension maximal voluntary isometric contractions: MVIC)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no conditioning exercise)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pre-test dominant leg MVIC F100 forces
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Post-test and post-10 min dominant leg MVIC F100 forces
Number of subjects: 32
Study: 32337229

Group type: EXPERIMENTAL
Intervention: Insoles with a toe-grip bar
Number of subjects: 52

Group type: COMPARATOR
Intervention: Regular insoles without a toe-grip bar
Number of subjects: 52
Study: 34232900

Group type: EXPERIMENTAL
Intervention: FTRPS measure for guilty group
Number of subjects: 30

Group type: COMPARATOR
Intervention: FTRPS measure for innocent group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Brain Fingerprinting Graphs (BFG) on delta, theta, alpha, and beta bands
Number of subjects: 30
Study: 34736525

Group type: EXPERIMENTAL
Intervention: Intensive management (treatment to induce remission)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable (anxiety, depression, health perceptions)
Number of subjects: 0
Study: 32391894

Group type: EXPERIMENTAL
Intervention: Disney movies during chemotherapy
Number of subjects: 50
Study: 36401084

Group type: EXPERIMENTAL
Intervention: ACE Inhibitors (ACEi)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Angiotensin Receptor Blockers (ARB)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Neither ACEi nor ARB
Number of subjects: 133
Study: 32580701

Group type: EXPERIMENTAL
Intervention: Nursing staff in dementia special care units, larger nursing homes, and nursing homes located in suburban/urban municipalities.
Number of subjects: 3693

Group type: EXPERIMENTAL
Intervention: Nursing staff overall
Number of subjects: 3693
Study: 34416898

Group type: EXPERIMENTAL
Intervention: Intraarticular injection of cell-free stem cell-derived extract (CCM)
Number of subjects: 12
Study: 32967871

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) levels measured by the Physical Activity Unit 7-item Screener
Number of subjects: 4508

Group type: EXPERIMENTAL
Intervention: Accelerometers worn by a representative subsample (10% of participants) for 9 days
Number of subjects: 4508

Group type: EXPERIMENTAL
Intervention: Validated questionnaires for adherence to the Mediterranean diet, quality of life, sleep duration, PA and sedentary behaviour
Number of subjects: 4508
Study: 35527596

Group type: EXPERIMENTAL
Intervention: Care manager support
Number of subjects: 269

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 269
Study: 33985404

Group type: EXPERIMENTAL
Intervention: Text-delivered counseling intervention
Number of subjects: 69

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 69
Study: 33879394

Group type: EXPERIMENTAL
Intervention: Modified surgical technique (group 2)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Standard surgical technique (group 1)
Number of subjects: 415
Study: 32978102

Group type: EXPERIMENTAL
Intervention: Home-Based Graduated Walking Program (HBGWP)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Fixed walking recommendation
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both interventions (HBGWP and fixed recommendation)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Increasing walking over time
Number of subjects: 54
Study: 33745379

Group type: EXPERIMENTAL
Intervention: Patient-controlled regional analgesia (PCRA)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Intravenous patient-controlled analgesia (IV-PCA)
Number of subjects: 134
Study: 32471106

Group type: EXPERIMENTAL
Intervention: Group A: 10,000 IU/day for eight weeks followed by 1000 IU/day for four weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group B: 50,000 IU/week for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group C: 100,000 IU/every other week for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 35382631

Group type: EXPERIMENTAL
Intervention: Flaxseed (30 g/day) for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 50
Study: 33550841

Group type: EXPERIMENTAL
Intervention: Psychoeducational HIV/STI prevention intervention
Number of subjects: 108
Study: 34911139

Group type: EXPERIMENTAL
Intervention: Salutogenic approach-based interviews
Number of subjects: 49
Study: 32363648

Group type: EXPERIMENTAL
Intervention: Internet addiction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smartphone addiction
Number of subjects: 0
Study: 34096759

Group type: EXPERIMENTAL
Intervention: Domain-specific Episodic Future Thinking (DS-EFT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Episodic Recent Thinking (ERT)
Number of subjects: 90
Study: 33867308

Group type: EXPERIMENTAL
Intervention: iPhone use with Night Shift enabled
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: iPhone use with Night Shift disabled
Number of subjects: 167

Group type: COMPARATOR
Intervention: No phone use
Number of subjects: 167
Study: 34633464

Group type: EXPERIMENTAL
Intervention: High-status model video
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-status model video
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no video)
Number of subjects: 0
Study: 32960007

Group type: EXPERIMENTAL
Intervention: Salbutamol combined with budesonide
Number of subjects: 98

Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 98
Study: 33009245

Group type: EXPERIMENTAL
Intervention: Scenario‐Tailored Opioid Messaging Program (STOMP)
Number of subjects: 604

Group type: COMPARATOR
Intervention: Routine instruction (Control)
Number of subjects: 604
Study: 32182336

Group type: EXPERIMENTAL
Intervention: Health warnings on sugar-sweetened beverages (SSBs)
Number of subjects: 400
Study: 35585944

Group type: EXPERIMENTAL
Intervention: Articaine and adrenaline combined with a computer‐controlled anesthesia system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Articaine and adrenaline anesthesia
Number of subjects: 100
Study: 34670754

Group type: EXPERIMENTAL
Intervention: Nutritional intervention with additional milk, yoghurt, and cheese providing 562 (166) mg/day calcium and 12 (6) g/day protein, achieving a total intake of 1142 (353) mg calcium/day and 69 (15) g/day protein (1.1 g/kg body weight)
Number of subjects: 7195

Group type: EXPERIMENTAL
Intervention: Nutritional intervention with additional milk, yoghurt, and cheese
Number of subjects: 7195

Group type: COMPARATOR
Intervention: Usual menus in control facilities
Number of subjects: 7195
Study: 32358697

Group type: EXPERIMENTAL
Intervention: schoolMAX intervention
Number of subjects: 103

Group type: COMPARATOR
Intervention: services‐as‐usual (SAU)
Number of subjects: 103
Study: 36332454

Group type: EXPERIMENTAL
Intervention: Telephone symptom triage protocol (TeleTRIAGE)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard nursing care
Number of subjects: 65
Study: 32970095

Group type: EXPERIMENTAL
Intervention: GWAS analysis in UKB cohort
Number of subjects: 172995

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 172995
Study: 33641545

Group type: EXPERIMENTAL
Intervention: Diabetes empowerment
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Diabetes distress
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Interaction effect of depression on diabetes distress and mastery
Number of subjects: 131
Study: 33642051

Group type: EXPERIMENTAL
Intervention: Lockdown (social distancing measures)
Number of subjects: 100
Study: 33008621

Group type: EXPERIMENTAL
Intervention: Broken Circle (BC) method
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: BC method (post-test)
Number of subjects: 256
Study: 35068330

Group type: EXPERIMENTAL
Intervention: Krocina™ (15 mg twice a day for six weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (same coating as Krocina™)
Number of subjects: 72
Study: 33719578

Group type: EXPERIMENTAL
Intervention: Research conducted in women
Number of subjects: 3

Group type: COMPARATOR
Intervention: Research conducted in men
Number of subjects: 3
Study: 32375491

Group type: EXPERIMENTAL
Intervention: Nurse-led Activate intervention (four behaviour change consultations over 3 months)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Nurse-led Activate intervention
Number of subjects: 195
Study: 34243211

Group type: EXPERIMENTAL
Intervention: Arm-cranking training with EMS (A+EMS)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Arm-cranking training without EMS (A)
Number of subjects: 25
Study: 33043475

Group type: EXPERIMENTAL
Intervention: Medical device (digital technology comprising an EAI smart case connected to a mobile APP)
Number of subjects: 100
Study: 32516744

Group type: EXPERIMENTAL
Intervention: 12-week home-based exercise program
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 110
Study: 35708696

Group type: EXPERIMENTAL
Intervention: Enzalutamide monotherapy (160 mg for 1 year)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Active Surveillance (AS)
Number of subjects: 227
Study: 36108484

Group type: EXPERIMENTAL
Intervention: Adaptation condition (belt speed ratio 1:3)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Baseline condition (belt speed ratio 1:1)
Number of subjects: 15
Study: 33197285

Group type: EXPERIMENTAL
Intervention: Pexidartinib (1000 mg/d for phase 1 extension study; 1000 mg/d for 2 weeks then 800 mg/d for ENLIVEN; 800 mg/d for crossover patients)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Pexidartinib
Number of subjects: 130
Study: 33731516

Group type: EXPERIMENTAL
Intervention: Sleep rate mode
Number of subjects: 9
Study: 32663998

Group type: EXPERIMENTAL
Intervention: Adjunctive Internet intervention (Deprexis)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Standard psychotherapy
Number of subjects: 340
Study: 35654660

Group type: EXPERIMENTAL
Intervention: HOMBRE intervention
Number of subjects: 424

Group type: COMPARATOR
Intervention: Minimal-intensity intervention
Number of subjects: 424
Study: 32446260

Group type: EXPERIMENTAL
Intervention: Shirodkar cerclage
Number of subjects: 350

Group type: COMPARATOR
Intervention: Control group (17-OH-progesterone treatment without cerclage)
Number of subjects: 350
Study: 32484534

Group type: EXPERIMENTAL
Intervention: CRP-guided antibiotic treatment duration (n=170)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: 7-day fixed antibiotic treatment duration (n=169)
Number of subjects: 504

Group type: COMPARATOR
Intervention: 14-day fixed antibiotic treatment duration (n=165)
Number of subjects: 504
Study: 36170304

Group type: EXPERIMENTAL
Intervention: Study group (residual bone height < 3 mm)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (residual bone height ≥ 3 mm)
Number of subjects: 87
Study: 34348323

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray for 3 weeks followed by surgical intervention for 3 months
Number of subjects: 31

Group type: COMPARATOR
Intervention: Fluticasone furoate nasal spray for 3 weeks followed by medical management for 3 months
Number of subjects: 31
Study: 32456874

Group type: EXPERIMENTAL
Intervention: Ofloxacin otic solution
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Gelatin sponge patch
Number of subjects: 136

Group type: COMPARATOR
Intervention: Spontaneous healing
Number of subjects: 136
Study: 33966790

Group type: EXPERIMENTAL
Intervention: Training program consisting of eight interactive sessions based on a Nursing Module on abuse among women with mental illness
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Training program
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 68
Study: 35183000

Group type: EXPERIMENTAL
Intervention: Tissue adhesive (2-octylcyanoacrylate)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Metal staples
Number of subjects: 66
Study: 34158387

Group type: EXPERIMENTAL
Intervention: Controlled Ankle Motion (CAM) boot
Number of subjects: 87

Group type: COMPARATOR
Intervention: Above-knee plaster of Paris cast (AK-POP)
Number of subjects: 87
Study: 32345699

Group type: EXPERIMENTAL
Intervention: isCGM
Number of subjects: 4

Group type: COMPARATOR
Intervention: standard care
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: ABC
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: ABC+isCGM
Number of subjects: 4
Study: 35644957

Group type: EXPERIMENTAL
Intervention: Mivacurium (0.25 mg/kg injected and continuously infused at 0.3 mg·kg‐1·h‐1)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Cisatracurium besylate (0.1 mg/kg injected, normal saline infused)
Number of subjects: 56